Background: With providers becoming more selective in ordering daily chemistry profiles, it is critical that profiles ordered are accurate. Contaminated electrolyte profiles are an overlooked and potentially dangerous source of inaccurate clinical data. This study aimed to develop a method to accurately identify electrolyte profiles contaminated with normal saline to prevent reporting of erroneous measurements. Methods: We conducted a retrospective cohort study of 76,497 electrolyte profiles from 5032 patients in a deidentified clinical database of all patients in the electronic medical record at Vanderbilt University Medical Center. Five methods to identify errors in quantification based on either deviations from observed concentration distributions or expected numerical changes from saline contamination were developed and tested. Potentially contaminated measurements were validated based on changes in electrolyte concentrations observed in the subsequent sample. Results: Identification of erroneous electrolyte profiles based on absolute and percent deviations from normal
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Background
As providers become more selective in ordering chemistry testing, it is critical that reported laboratory data is accurate. While numerous efforts are made to minimize inaccurate laboratory measurements, errors in sample collection, storage, analysis, or reporting can result in erroneous measurement that alter a provider's perception of a patient's clinical progress and cause unnecessary and potentially harmful interventions [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Saline-contaminated samples represent a specific example of inaccurate measurements. While serum is usually discarded prior to sample collection, samples contaminated with saline during collection can still occur and lead to inaccurate measurement of electrolytes, inappropriate electrolyte replacement, unnecessary additional testing, and misinterpretation of a patient's true clinical status [13, 14] . The contamination of blood samples with saline is of particular concern given the high prevalence of venous access devices during patient hospitalization, the frequency with which chemistry panels are ordered, and the practical difficulty of estimating deadspace volume when discarding initial sample [13, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] .
Methods are needed to identify instances where there is a high likelihood of sample contamination by saline to avoid inappropriate treatment and testing. The aim of this study was to develop and validate a standardized method to identify electrolyte profiles contaminated with saline so they can be flagged and reported to providers prior to their integration into clinical care.
Materials and methods

Study design and population
We performed a retrospective cohort study of all records from adult and pediatric patients seen at Vanderbilt University Medical Center, a large tertiary care medical center in Nashville, TN, between 1994 and 2013. Records were screened for documentation of an electrolyte profile, defined as simultaneous quantification of the concentrations of chloride, calcium, creatinine and potassium from a single blood draw. Of the 2,323,149 records screened, 668,701 (28.8%) had documentation of an electrolyte profile and a random sample of 18,545 (2.8%) records containing 278,182 electrolyte profiles were selected for further analysis. Electrolyte profiles were included in analysis if they were both preceded and followed by an additional electrolyte profile within 48 h of collection. A total of 76,497 (27.5%) from 5032 unique records met criteria and were included in analysis. This selection process is shown in Figure 1 .
Data source
The Synthetic Derivative (SD), a database of over 2.3 million deidentified patient records at Vanderbilt University Medical Center in Nashville, TN, USA was used for this study. All tests, imaging reports, significant clinical encounters, laboratory measurement, and provider coding in Vanderbilt's electronic medical records are stripped of identifying information and stored in SD which can then be searched based on structured and unstructured queries. Use of the SD is classified as non-human research by Vanderbilt University's Institutional Review Board who approved this study.
Laboratory analyzers
Vanderbilt University Medical Center's clinical laboratory used the Roche Modular system prior to March 2007 when it switched to the Beckman Coulter UniCel DxC 800. This system was in place until September 2013 at which point the Abbott Architect Chemistry Analyzer (c8000 and c16000) was adapted. Specifications for each analyzer are available on their respective websites [26] [27] [28] . Analyzers are calibrated every 8 h for basic electrolyte profiles to ensure continued accuracy over time.
Identification of contaminated electrolyte profiles
Five separate models, summarized in calcium and chloride were used in the methods as they had significant concentration differences between blood and normal saline and the least variability between consecutive samples, as shown in the probability density function plots. Models 1-3 assessed the electrolyte concentrations and changes in concentration within the context of their overall distributions to identify electrolyte profiles suspicious for contaminant. Methods 4 and 5 used predicted concentration changes due to saline contamination to guide identification. Specifically, a new quantity called percent dilution towards saline was developed to estimate the proportion of saline contaminant needed to obtain the observed concentration changes for chloride and calcium. Method 4 identified patient when the percent dilution towards saline for calcium and chloride were both above a cut-off value while Method 5 identified patient if the average of the percent dilution towards saline for calcium and chloride were above a cut-off value. Full description of the methods and example calculations are provided in the Supplemental Methods (Supplementary Material that accompanies the article http://www.degruyter. com/view/j/cclm.2015.53.issue-10/cclm-2015-0955/cclm-2015-0955. xml?format=INT.). 
Validation of contaminated electrolyte profiles
Two methods were used to validate electrolyte profiles as contaminated. Method 1 validated profiles if the electrolyte changes on the subsequent electrolyte profile were outside the usual distribution of changes in concentration. Method 2 validated profiles based on the observed concentration changes on the subsequent electrolyte profile relative to the previous electrolyte profile. Specifically, a measurement called return to previous was created which quantifies the proportion the concentration on the subsequent electrolyte profile shifted towards the preceding profile. If the return to previous was > 50% for the electrolyte(s) being tested, the profile was validated as contaminated. Full description of the methods and example calculations are provided in the Supplemental Methods.
Sensitivity analysis
Additional analyses were done to assess the sensitivity of the proposed methods. The model was assessed separately on pediatric (age < 18 years) and adult (age ≥ 18 years) populations to determine if the methods remained accurate. Also, analysis based on date of electrolyte profiles was assessed to control for advances in technology or changes in calibration methods over time. Cut-off years were selected as to split the electrolyte profiles into approximately three equal sized cohorts. Separation based on analyzer use was not possible as dates within Synthetic Derivative are randomly shifted up to 1 year to ensure patient anonymity, thus preventing identification of analyzer used in quantification.
Results
A total of 76,497 electrolyte profiles from 5032 patients (15.2 electrolyte profiles/patient, median 23.2 h between consecutive profiles) were included in this study. The demographics of patients with qualifying electrolyte The demographics of patients with qualifying electrolyte profiles is shown here.
profiles and distribution of the year of electrolyte profiles are shown in Table 2 . Due to deidentification methods utilized by SD to ensure patient anonymity, only limited demographic information is available. Still, there was no significant gender predominance with 51.6% males and 48.2% female. The majority of patients were Caucasian (70.3%), with a significant number of African American patients (13.0%) and patients with unknown race (13.3%). The mean patient age was 53.8 years with a standard deviation of 24.1 years. A large percentage of patients were elderly with 37.3% of patients over the age of 65. Children under the age of 18 represented 11.6% of the population. The majority of the electrolyte profiles were from between the years 2009 and 2012. The probability density function and cumulative density function of the concentration, absolute change in concentration, and percent change in concentration for each electrolyte is shown in Figure 2 . Notable percentiles within the distributions are shown in Supplemental Table 1 . The overall distribution of the concentrations of chloride, calcium and potassium followed an approximately normal distribution centered around 105, 8.6, and 3.9 mmol/L, respectively, with standard deviations of 6.47, 0.84, and 0.65 mmol/L, respectively. The distribution of creatinine is skewed to the right with a median of 1000 μmol/L, mean of 1500 μmol/L, interquartile range of 700-1700 μmol/L and standard deviation of 1670 μmol/L. Both the absolute and percent change in concentration of each electrolyte followed approximately normal distributions with means centered around zero. Creatinine and potassium had the highest percent variability between consecutive draws with standard deviations of 21.4% and 15.9%, respectively, which correlated to absolute changes of 500 μmol/L and 0.61 mmol/L. Chloride and calcium had significantly lower percent variability between consecutive draws with standard deviations of 3.7% and 7.6%, respectively, which correlated to absolute changes of 3.77 mmol/L and 0.58 mmol/L. Figure 3 shows the relationship between proportion of samples identified as contaminated and proportion of identified samples verified as contaminated for each identification methods. Both calcium and chloride were used in each identification methods and Validation Method 2 was used for each to ensure consistency in methodology and to allow for comparison between identification methods. These methods were representative of the overall trends for each electrolyte, identification method and validation method, shown in Supplemental Figures  1-5 . Identification Methods 4 and 5 outperformed Identification Methods 1-3 at all identification rates, especially at lower identification rates.
The proportion of profiles identified as contaminated and proportion of identified profiles confirmed as contaminated as a function of cut-off for dilution towards saline is shown in Figure 4 for Identification Methods 4 and 5. Validation Method 2 was used for The sensitivity of the methodology was tested by comparing the pediatric and adult populations separately and by stratifying the electrolyte profiles by year of test. Supplemental Figure 6 shows the identification and confirmation rates as a function of cut-off values based on these stratifications. Identification Method 4 and Validation Method 2 were used for these analyses. The identification and validation rates are similar for both pediatric and adult populations and for each time interval tested.
Discussion
This study established a method to identify electrolyte profiles contaminated with saline. While identification of samples based on absolute concentrations or changes in concentration alone did not result in accurate selection, a targeted approach based on the expected concentration changes in calcium and chloride due to contamination with saline successfully predicted erroneous electrolyte profiles. Using cut-offs of 25% minimum dilution towards saline for calcium and chloride or 29% average dilution towards saline, 80% samples identified as contaminated were validated based on statistical and laboratory parameters. Further clinical confirmation and implementation of this method could reduce unnecessary diagnostic workups and unwarranted treatments due to erroneous laboratory measurements [29, 30] .
Our findings offer a new method to assess for laboratory error. Prior studies have focused on critical laboratory values and screened for single electrolyte concentrations. Identification based on critical measurements or changes in single electrolyte concentration have been shown to be ineffective, yet is still frequently done resulting in time delays in measurement reporting [31] [32] [33] [34] . An integrated approach based on changes in multiple electrolytes within a single blood draw that successfully identify contaminated samples has not previously been developed.
Given the reliability and potential benefits of the proposed methods, an automated mechanism within the laboratory reporting system that warns providers of possible contaminated electrolyte profiles could help decrease erroneous laboratory measurements. This could decrease unwarranted electrolyte repletion and prevent integration of inaccurate data in a patient's clinical picture that may otherwise result in costly clinical tests and potential extension of hospitalizations. Further, contaminated samples can be investigated to determine if certain circumstances, such as patient demographics, urgency of provider orders, clinical acuity, or operator technique, affects likelihood of contamination and ultimately lead to interventions that decrease the incidence of contamination in all serum testing.
The identification methods that detected electrolyte profiles consistent with saline contamination were developed based on numerous clinical and physiological features. Chloride and calcium were selected as they have significant concentration differences between blood and saline (approx. 105 mmol/L vs. 154 mmol/L and approx. 9 mmol/L vs. 0 mmol/L, respectively) compared with sodium (approx. 140 mmol/L vs. 154 mmol/L) meaning saline contamination would result in significant and predictable changes in the measured electrolyte concentration. Calcium and chloride also had less variability between consecutive profiles than potassium and creatinine (standard deviations for percent change between consecutive samples of 7.6% and 3.7% compared to 15.9% and 21.4%, respectively) meaning large numerical changes in their concentrations were more likely due to contamination than in vivo changes.
Despite the use of robust methods to identify and confirm potential laboratory errors, certain limitations of this work must be acknowledged. First, this study was done at a single center and error rates during collection of samples and precision of measurements may differ by institution. Still, similar electrolyte changes would be expected with saline contamination and our results were consistent throughout multiple time periods tested, despite advances in technology. Next, while multiple validation techniques were used, this was a retrospective study and verification of contamination was based on laboratory and statistical methods rather than a true gold standard, such as immediate repeat serum testing. This validation method may have under-estimated the extent of the contamination, as we were unable to validate one-fifth of samples using this method. Prospective clinical validation of the proposed methods has not yet been completed and will need to be performed to further define the magnitude of the contamination. We also were unable to examine laboratory errors laboratory samples that occur upon patient presentation to the hospital or in patients for whom a recent electrolyte profile is not available. An alternate method would need to be used in these situations. Finally, the use of a 48-h cut-off is arbitrary, and we assume that electrolyte concentrations are approximately stable in the intervening time. Although the electrolytes chosen have low day-to-day variation and are rarely intervened upon, the true serum electrolyte concentration may change between draws due to interventions to correct laboratory abnormalities or changes in clinical status [35, 36] .
Conclusions
Using a large retrospective database, we developed a method based on expected concentration changes that identifies electrolyte profiles suspicious for contamination. These methods can be integrated into the electronic reporting system to alert providers of possible contamination and trigger redraw of samples so that data from saline contaminated samples is not reported. This could prevent inappropriate interventions, change in treatment strategy and misinterpretation of a patient's clinical course due to inaccurate clinical data.
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